Researcher examines mechanism underlying abdominal pain in pancreatic cancer

March 1, 2013

Erxi Wu, assistant professor of pharmaceutical sciences, co-wrote the article, "Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells," which was published by Molecular Cancer Research, an American Association for Cancer Research journal. 

According to the authors, pancreatic cancer significantly affects the quality of life due to the severe abdominal pain. However, the underlying mechanism is not clear. This study aimed to determine the relationship between substance P and pancreatic cancer perineural invasion, as well as mechanism of substance P mediating pancreatic cancer perineural invasion which cause pain in patients with pancreatic cancer. 

The authors showed that substance P is not only widely distributed in the neurite outgrowth from newborn rat dorsal root ganglions but also expressed in . NK-1R is found to be overexpressed in the pancreatic cancer cell lines tested. Substance P induces cancer and invasion and the expression of MMP-2 in pancreatic ; and NK-1R antagonists inhibit these effects. Furthermore, substance P is also able to promote neurite outgrowth and the migration of pancreatic cancer cell cluster to the dorsal root ganglions, which is blocked by NK-1R antagonists in the co-culture model. 

"Our results suggest that substance P plays an important role in the development of pancreatic and perineural invasion, and blocking the substance P /NK-1R signaling system is a novel strategy for the treatment of pancreatic cancer," Wu said, noting the paper was co-written with Qingyong Ma lab at Xi'an Jiaotong University, China. "Collaborating with Dr. Ma, we together would like to find better and elucidate the mechanisms of the targeted therapy for pancreatic cancer," Wu said. 

Wu's research interests include tumor therapeutic targets, drug discovery and biomarkers. For more information about Wu's lab, visit 

Explore further: Pharmaceutical sciences researchers to publish paper

Related Stories

Pharmaceutical sciences researchers to publish paper

November 15, 2011

Erxi Wu, assistant professor of pharmaceutical sciences, and Shuang Zhou, doctoral student of pharmaceutical sciences in Wu’s lab, co-wrote the article, "High glucose promotes pancreatic cancer cell proliferation via ...

Researchers to publish paper in Molecular Cancer journal

December 7, 2011

(Medical Xpress) -- Erxi Wu, assistant professor of pharmaceutical sciences, and Fengfei Wang, research associate in pharmaceutical sciences, co-wrote the article, "β2-adrenoceptor blockage induces G1/S phase arrest ...

Nerve growth factors elevated in pancreatic cancer model

June 19, 2012

Severe pain is a major symptom of pancreatic cancer. The results of a new study show that four different factors involved in the growth and maintenance of nerves are elevated in a mouse model of pancreatic cancer. This is ...

Researchers link stress and pancreatic cancer in new paper

February 15, 2013

Pancreatic cancer is a deadly disease with increased incidences in the recent years. According to NDSU researchers, epidemiological data show chronic stress in a negative social and psychological state such as depression ...

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.